Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severity and treatment response are linked to specific cytokine levels.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Regulatory T cells are essential for normal and improved wound healing in mice.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Old people have less hair because their hair follicles don't regenerate as well, not because of fewer stem cells, and a protein called follistatin might help reactivate hair growth.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Stem cell vesicles reduced eczema symptoms in mice safely.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Dupilumab improves eczema in Netherton Syndrome but not ichthyosis linearis circumflexa.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Targeting specific cell interactions may help treat skin fibrosis.

Certain drugs may cause vitiligo, so patients should be monitored.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Biologics for severe asthma have known side effects, but some new risks need more study.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

NK cells play a role in skin diseases like eczema and psoriasis.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.